Fil d'actualités

Filtrer
  • VIH
sympo sat
20
Nov
2017

Isoniazid preventive therapy (IPT): Time to use it !  "Science has spoken"

  • VIH
Abidjan ANRS TEMPRANO
10
Oct
2017

Long-term follow-up in the ANRS TEMPRANO trial confirms that tuberculosis chemoprophylaxis in HIV-infected people is more than ever relevant in resource-limited countries.

  • VIH
  • Hépatites
Café cigarette
27
Sep
2017

A study from the ANRS HEPAVIH prospective cohort is the first to investigate the relationship between coffee consumption and the risk of all-cause mortality in HIV-HCV co-infected patients. Indeed, coffee is known to…

26
Jul
2017

No link between antiretroviral treatment and fracture risk

  • VIH
  • Hépatites
Café
26
Jul
2017

HIV/HCV: effects of coffee and cannabis

  • VIH
Biofilm viral
26
Jul
2017

A protective extracellular matrix underpins HIV infectivity

  • Hépatites
Image issue d'un film réalisé par Mr Hà Quang Hiêp membre du groupe d'UDI Friendship Arm.
25
Jul
2017

Drug users in the South: access to HCV treatment

  • VIH
Homosexuels
25
Jul
2017

On-demand PrEP and infrequent sexual intercourse

  • VIH
Côte d'Ivoire
24
Jul
2017

Efficacy of third-line therapy in resource-limited countries

  • Hépatites
TAC Karine Lacombe
24
Jul
2017

HCV treatment: results of the first clinical trial in Africa